AKT1 and prostate carcinoma: Moreover, overexpression of TPD52 leads to an increase in cell proliferation and phosphorylation of protein kinase B (Akt) in prostate cancer [26,27,28] and protects these cells from apoptosis induced by androgen deprivation [27].